[PR Newswire] - BOULDER, Colo., June 4, 2013 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that it has priced its previously announced offering of convertible senior notes in an underwritten public ...
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment